Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DRD2 encodes the D2 subtype of the dopamine receptor. Additionally we are shipping Dopamine d2 Receptor Kits (38) and Dopamine d2 Receptor Proteins (9) and many more products for this protein.
Showing 10 out of 105 products:
Human Polyclonal Dopamine d2 Receptor Primary Antibody for IF (p), IHC (p) - ABIN730858
Xu, Wang, Chen, Chen, Li, Shao, Li, Lu, Zhou: Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells. in Acta pharmacologica Sinica 2014
Show all 6 references for ABIN730858
Human Polyclonal Dopamine d2 Receptor Primary Antibody for EIA, WB - ABIN951970
Verma, Hasbi, ODowd, George: Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2. in The Journal of biological chemistry 2010
Show all 5 references for ABIN951970
Human Polyclonal Dopamine d2 Receptor Primary Antibody for EIA, IHC (fro) - ABIN492908
Farooqui, Brock, Hamdi, Prasad: Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. in Journal of neurochemistry 1991
Show all 3 references for ABIN492908
Human Polyclonal Dopamine d2 Receptor Primary Antibody for EIA, IHC (fro) - ABIN492910
Farooqui, Prasad: An antibody to dopamine D2 receptor inhibits dopamine antagonist and agonist binding to dopamine D2 receptor cDNA transfected mouse fibroblast cells. in Life sciences 1992
Show all 2 references for ABIN492910
Human Monoclonal Dopamine d2 Receptor Primary Antibody for ELISA, WB - ABIN515070
Akimoto, Furuse: SCH23390, a dopamine D1 receptor antagonist, suppressed scratching behavior induced by compound 48/80 in mice. in European journal of pharmacology 2011
Mouse (Murine) Polyclonal Dopamine d2 Receptor Primary Antibody for WB - ABIN1742096
Kehne, Andree, Heinrich: D2 receptor partial agonists: treatment of CNS disorders of dopamine function. in Current topics in medicinal chemistry 2008
Results suggest that the activation state of DAMB protein contributes to oxidative stress susceptibility in Drosophila and lead to a proposed model for paraquat neurotoxicity.
Mapped associations occur between changes in D2 and D3 dopamine receptor (show DRD3 Antibodies) occupancy and brain hemodynamics
These data provide evidence for a predisposition to self-administer cocaine based on dopamine D2 receptor availability, and demonstrate that the brain dopamine system responds rapidly following cocaine exposure.
The amount of dopamine d1 receptor (show DRD1 Antibodies), dopamine D2 receptor, and follicle stimulating hormone receptor (show FSHR Antibodies) mRNA were quantified in ovarian tissues in anestrous and mares expressing estrus during the breeding season are reported.
The pig DRD2 gene was cloned, investigated its distribution in tissues and polymorphisms were identified.
The increase in NOS (show NOS Antibodies) protein seen in both the endothelium and vascular smooth muscle in response to cerebral vasospasm is enhanced by dopamine in a D(2)R-dependent mechanism.
DRD2 gene expression reduction in breast cancer patients after spiritual intervention
No significant differences in age (p = 0.60), mean methadone dose (p = 0.75) or borderline index group (p = 0.25) were observed between subjects bearing the B1/B1, B1/B2 and B2/B2 DRD2 TaqI genotypes. Although the DRD2 TaqI B genotype was not associated with methadone use requirements, borderline index was revealed as a potential predictive marker for the adjustment of methadone dosage requirements in heroin addicts.
Striatal functioning is impaired in carriers of the DRD2 risk allele, likely due to dopamine dysregulation at the DRD2 location.
No statistically significant differences were found between cases and controls for the allele frequencies in five genes: TH, SLC18A2 (show Slc18a2 Antibodies), DRD1 (show DRD1 Antibodies), DRD3 (show DRD3 Antibodies) and COMT (show COMT Antibodies). Conversely, some alleles of the 12 sNPs from the DRD2 locus and the 5 from the MAOA (show MAOA Antibodies) locus showed significant associations with excessive alcohol consumption.
Study examined the implications of variations of selected, dopamine-relevant polymorphisms (DRD2 Taq1A, DRD4 (show DRD4 Antibodies) 7R, and COMT (show COMT Antibodies)) for risk of substance abuse in women with binge-purge eating syndromes
Study found several associations between Catechol-O-Methyl Transferase (COMT (show COMT Antibodies) val158met) and Dopamine D2 Receptor (DRD2 G>T) genetic profile, motor performance, and sensorimotor adaptation. More importantly, we found that this association varies with age, task type, and engagement of implicit versus explicit learning processes
a comprehensive residue interactions network of both dopamine bound WT and mutant DRD2 protein were studied. We also employed a protein-protein docking strategy to find the interactions of scaffold proteins - Galphai/o and NEB2 with both dopamine bound WT and mutant structures of DRD2
These findings suggest that the interaction of DRD2 rs1079597 and MAOA (show MAOA Antibodies) rs309850 3-repeat affects smoking intensity in young Taiwanese men.
he interaction effects of 5-HTTLPR (show SLC6A4 Antibodies) x Earthquake Exposure and 5-HTTVNTR x Earthquake Exposure were statistically significant
DRD2 polymorphisms play a role in the prolactin (show PRL Antibodies) response seen in risperidone-treated children with autism spectrum disorders.
Data indicate a contribution of D2 dopamine receptors to the effects of repetitive transcranial magnetic stimulation (rTMS) on postsynaptic density protein-95 (PSD-95 (show DLG4 Antibodies)) and cyclin-dependent kinase 5 (CDK5 (show CDK5 Antibodies)) levels.
These results suggest that DRD2 activation is involved in alleviation of CIA (show NCOA5 Antibodies) symptoms by amelioration of Th17/Treg imbalance.
Study demonstrated that chronic social defeat stress induced increased expression of DRD2 dimers in the prefrontal cortex of susceptible and/or unsusceptible mice
Through a combination of pharmacological and genetic tools, study provides convergent evidence of D2 (rather than D1) pathway dominant effects of PDE10A (show PDE10A Antibodies) inhibition in rodents
reveal differential roles of dopamine D1 receptor (show DRD1 Antibodies) - and dopamine D2 receptor -containing accumbal shell neurons in the development of behavioral sensitization to psychostimulants
Data indicate the responses of dopamine receptors D1- and D2-type medium spiny neurons (MSNs) in nucleus accumbens (NAc (show NLRP1 Antibodies)) to acute cocaine and during the formation of context-reward association.
This shows that mood stabilizers lamotrigine, lithium and valproate can exert behavioral effects in mice by disrupting the beta-arrestin 2 (show ARRB2 Antibodies)-mediated regulation of Akt (show AKT1 Antibodies)/GSK3 (show GSK3b Antibodies) signaling by D2 dopamine receptors.
psychostimulants induce downregulation of DRD1a (show DRD1 Antibodies) and DRD2 mRNA expression and upregulation of tyrosine hydroxylase (show TH Antibodies) protein expression in the testis
The results reveal that isoform D2S, but not D2L receptors, exhibited calcium-dependent desensitization similar to that exhibited by endogenous autoreceptors.
Our results show that D2R controls renal inflammation, at least in part, by modulation of the Akt (show AKT1 Antibodies) pathway through effects on PP2A (show PPP2R2B Antibodies) activity/expression.
Studied a novel Dopamine Receptor 2 (DRD2) G/A SNP for resistance to fescue toxicosis.
Dopamine D2 receptor play role in memory consolidation.
This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia\; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.
, D[]-like receptor
, dopamine receptor 2
, dopamine receptor in mushroom bodies
, dopamine-2 receptor
, D(2) dopamine receptor
, D2 dopamine receptor
, Dopamine D2 receptor
, dopamine receptor D2b
, dopamine D2 receptor 1
, dopamine D2 receptor 2
, D(2) dopamine receptor A
, D2R 1
, dopamine receptor D2
, dopamine D2 receptor
, dopamine receptor D2 isoform
, seven transmembrane helix receptor
, D2 receptor
, dopamine receptor 2 protein